Single probit model | Bivariate probit model | |||
---|---|---|---|---|
Marginal effect (95% C.I.) | Marginal effect (95% C.I.) | |||
Age (by 10 years) | 0.002* | ( 0.000, 0.004) | 0.002 | (-0.000, 0.003) |
Gender (Female) | -0.000 | (-0.004, 0.003) | -0.000 | (-0.003, 0.002) |
mRS pre-admission | ||||
mRS = 0 | - | |||
mRS = 1 | -0.001 | (-0.006, 0.003) | -0.001 | (-0.005, 0.002) |
mRS = 2 | 0.003 | (-0.004, 0.010) | 0.002 | (-0.004, 0.008) |
mRS = 3 | 0.003 | (-0.004, 0.010) | 0.002 | (-0.003, 0.007) |
Functional severity score¶ | 0.004** | (0.003, 0.006) | 0.003* | (0.001, 0.006) |
Functional capability score¶ | 0.002* | (0.000, 0.003) | 0.001 | (-0.000, 0.002) |
Co-morbidity index (CI > 2) | 0.003 | (-0.001, 0.006) | 0.002 | (-0.001, 0.005) |
Use of edaravone | 0.002 | (-0.002, 0.005) | 0.001 | (-0.002, 0.005) |
VEI | 0.003 | (-0.000, 0.006) | 0.001 | (-0.013, 0.016) |
Training intensity | -0.005** | (-0.007, -0.003) | -0.004* | (-0.007, 0.000) |
First stage regression | ||||
Friday admission | -0.001 | (-0.002, 0.000) |